Intelligent Analysis for Improving The Clinical Pathway of Lung Cancer

In order to make a best treatment plan for different patients of lung cancers, the prognosis of disease's development and its influence factors should be evaluated and analyzed accurately. In the traditional clinical pathway, we can only consider the linear classification of those factors or divide them into different stages. This paper proposed an effective machine learning method based on the combination of Cox regressive model and BP-GA neural network to predict the patient's expectation of survival rate, and so as to find the best treatment regime for each different patient. After the above intelligent analysis, the treatment decision procedures were presented for improving the current clinical pathway of lung cancer, and had been designed into the decision support system based on Hadoop system and Spring cloud framework for distributed applications of doctor's workbench system or mobile terminals from hospitals.

[1]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.

[2]  S. Burdett,et al.  Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.

[3]  C. Gridelli Chemotherapy of advanced non small cell lung cancer in the elderly: an update. , 2000, Critical reviews in oncology/hematology.

[4]  R. Yancik,et al.  Aging and cancer in America. Demographic and epidemiologic perspectives. , 2000, Hematology/oncology clinics of North America.

[5]  Kazumichi Yamamoto,et al.  Surgical results of stage I non-small cell lung cancer: comparison between elderly and younger patients. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  J. Padilla,et al.  [Stage I nonsmall cell lung cancer up to 3 cm in diameter. Prognostic factors]. , 2004, Archivos de bronconeumologia.

[7]  M. Okada,et al.  Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection. , 2004, The Annals of thoracic surgery.

[8]  H. Nakamura,et al.  Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis , 2005, British Journal of Cancer.

[9]  Ara A Vaporciyan,et al.  Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome. , 2005, Radiology.

[10]  A. Rossi,et al.  Chemotherapy of advanced non-small cell lung cancer in elderly patients. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  S. Ou,et al.  Prognostic factors for survival of stage I non-small cell lung cancer (NSCLC) patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry (CCR) from 1989 to 2003: A4-07 , 2007 .

[12]  Joe Y. Chang,et al.  Clinical Investigation : Thoracic Cancer Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly , 2012 .

[13]  G. Prisadov,et al.  Size of tumour as a risk factor for malignancy in patients with peripheral pulmonary nodules , 2012, Folia medica.

[14]  Joe Y. Chang,et al.  Comparative effectiveness of five treatment strategies for early-stage non-small cell lung cancer in the elderly. , 2012 .

[15]  J. Usuda,et al.  Pathological Vascular Invasion and Tumor Differentiation Predict Cancer Recurrence in Stage ia Non–Small-Cell Lung Cancer After Complete Surgical Resection , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  Yih-Leong Chang,et al.  The Significance of Visceral Pleural Surface Invasion in 321 Cases of Non-Small Cell Lung Cancers with Pleural Retraction , 2012, Annals of Surgical Oncology.

[17]  Y. Liu,et al.  91例小细胞肺癌预后的回顾性多因素分析 , 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[18]  A. Sihoe,et al.  Non-small cell lung cancer: when to offer sublobar resection. , 2014, Lung cancer.

[19]  Frank C. Detterbeck,et al.  The Eighth Edition Lung Cancer Stage Classification , 2017, Chest.

[20]  Nishita Mehta,et al.  Concurrence of big data analytics and healthcare: A systematic review , 2018, Int. J. Medical Informatics.

[21]  Mohammad Nazir Ahmad,et al.  Analyzing diffusion patterns of big open data as policy innovation in public sector , 2019, Comput. Electr. Eng..

[22]  Panagiota Galetsi,et al.  Big data analytics in health sector: Theoretical framework, techniques and prospects , 2020, Int. J. Inf. Manag..